Karyopharm Therapeutics reported $302.29M in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
AstraZeneca AZN:LN 30781M 1131M
Avrobio Inc AVRO:US $ 15.02M 75K
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 31025M 3218M
Sangamo Biosciences SGMO:US $ 0M 0M
Tg Therapeutics TGTX:US $ 67.76M 51.14M